DelveInsight

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.


Research Reports By DelveInsight

Found 2494 publications
Hemlibra- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Xospata- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Radicava- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Ocrevus- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Bevyxxa- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Nerlynx- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Galafold- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Vosevi- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Balversa- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Mayzent- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Fasenra- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Verzenio- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Mavyret- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Dupixent- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Parsabiv- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Erleada- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Tremfya- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Rydapt- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Imfinzi- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Symproic- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Lutathera- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Biktarvy- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
Symdeko- Drug Insight, 2019 US$ 1,000.00 Jul, 2019 35 pages
1 2 3 4 5 ... 50
Skip to top

Analytics & News by DelveInsight